AlloVir (ALVR) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

ALVR is expected to report earnings to rise 90.00% to -9 cents per share on November 29

Q3'24

Est.

$-0.09

Q2'24

Beat

by $0.04

Q1'24

Missed

by $0.02

Q4'23

Missed

by $0.05

Q3'23

Beat

by $0.03

The last earnings report on August 01 showed earnings per share of -5 cents, beating the estimate of -9 cents. With 75.12K shares outstanding, the current market capitalization sits at 54.67M.

View a ticker or compare two or three

Compare

ALVR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALVR
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1100 Winter Street

Phone

+1 617 433-2605

Employees

112

Web

https://www.allovir.com